EUVIMEDEUVIMED entdecken
Crossref

Cisatracurium besylate rescues Mycobacterium Tuberculosis-infected macrophages from necroptosis and enhances the bactericidal effect of isoniazid

Qian Wen, Jing Zhang, Zhanqing Zhang, Liru Chen, Honglin Liu, Zhenyu Han, Yaoxin Chen, Ke Wang, Jieyu Liu, Na Sai, Xinying Zhou, Chaoying Zhou und 2 weitere

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Qian Wen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Immunology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Tuberculosis is the leading killer among the chronic single-source infectious diseases. Mycobacterium tuberculosis can induce necrotic-dominant multiple modes of cell death in macrophages, which accelerates bacterium dissemination and expands tissue injury in host lungs. Mining drugs to counteract Mycobacterium tuberculosis-induced cell death would be beneficial to tuberculosis patients. METHODS: In this study, the protective drug was screened out from the FDA-approved drug library in Mycobacterium tuberculosis-infected macrophages with CCK-8 assay. The death mode regulated by the drug was identified using transcriptomic sequencing, cytomorphological observation, and in the experimental mouse Mycobacterium tuberculosis-infection model. The functional mechanism was explored using western blot, co-immunoprecipitation, and DARTS assay. The intracellular bacterial survival was detected using colony forming unit assays. RESULTS: Cisatracurium besylate was identified to be highly protective for the viability of macrophages during Mycobacterium tuberculosis infection via inhibiting necroptosis. Cisatracurium besylate prevented RIPK3 to be associated with the executive molecule MLKL for forming the necroptotic complex, resulting in the inhibition of MLKL phosphorylation and pore formation on cell membrane. However, Cisatracurium besylate did not interfere with the association between RIPK3 with its upstream kinase RIPK1 or ZBP1 but regulated RIPK3 autophosphorylation. Moreover, Cisatracurium besylate significantly inhibited the expansion of intracellular Mycobacterium tuberculosis both in vitro and in vivo, which also displayed a strong auxiliary bacteriostatic effect to support the therapeutic efficacy of isoniazid and rifampicin, the first-line anti-tubercular drugs. CONCLUSION: Cisatracurium besylate performs anti-Mycobacterium tuberculosis and anti-necroptotic roles, which potentiates its application to be an adjuvant drug for antituberculosis therapy to assist the battle against drug-resistant tuberculosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosisMiceAnimalsApoptosisIsoniazidNecroptosisProtein KinasesAnti-Bacterial AgentsReceptor-Interacting Protein Serine-Threonine KinasesMacrophagesAtracurium

Stichwörter der Autor:innen

Cisatracurium besylateMLKLMycobacterium tuberculosisNecroptosisRIPK3

Substanzen

IsoniazidProtein KinasesAnti-Bacterial AgentsReceptor-Interacting Protein Serine-Threonine KinasescisatracuriumAtracurium

Autor:innen und Institutionen

  • Institute of Molecular Immunology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, China.
  • Institute of Molecular Immunology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, China. Electronic address: mali_61648322@smu.edu.cn.

Förderung

  • National Key Research and Development Program of China
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • National Natural Science Foundation of China

Zitieren

APA

Wen, Q., Zhang, J., Zhang, Z., Chen, L., Liu, H., Han, Z., Chen, Y., Wang, K., Liu, J., Sai, N., Zhou, X., Zhou, C., Hu, S., & Ma, L. (2023). Cisatracurium besylate rescues Mycobacterium Tuberculosis-infected macrophages from necroptosis and enhances the bactericidal effect of isoniazid. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110291

Vancouver

Wen Q, Zhang J, Zhang Z, Chen L, Liu H, Han Z, et al. Cisatracurium besylate rescues Mycobacterium Tuberculosis-infected macrophages from necroptosis and enhances the bactericidal effect of isoniazid. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110291

BibTeX
@article{Wen2023,
  author = {Wen, Qian and Zhang, Jing and Zhang, Zhanqing and Chen, Liru and Liu, Honglin and Han, Zhenyu and Chen, Yaoxin and Wang, Ke and Liu, Jieyu and Sai, Na and Zhou, Xinying and Zhou, Chaoying and Hu, Shengfeng and Ma, Li},
  title = {Cisatracurium besylate rescues Mycobacterium Tuberculosis-infected macrophages from necroptosis and enhances the bactericidal effect of isoniazid},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110291}
}
Kostenlos starten →